Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocugen, Inc. - Common Stock (NQ:OCGN)

0.6362 -0.0025 (-0.39%)
Streaming Delayed Price Updated: 11:34 AM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
33 34 Next >
Why Ocugen Stock Is Rallying While Moderna, Novavax, Vaxart Can't Catch Up
Ocugen Inc. (NASDAQ:OCGN) shares were trading higher Tuesd... 
Via Benzinga
Most Active Equity Options For Midday - Tuesday, Oct. 12
Top Tickers: TSLA, AAPL, FB, F, T, MU, PROG, SOFI, FCX, BABA, BBIG, WKHS, OCGN, NVDA, AMC, AMD, MGM, BAC, AMZN, NIO. 
Via Talk Markets
Benchmarks Muted After Slashed Global Growth Forecast
The major indexes are struggling for direction this afternoon after fresh data from the U.S. Labor Department showed job openings in August fell sharply to 10.4 million, while workers quit retail and... 
Via Talk Markets
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers NRX Pharmaceuticals (NASDAQ:NRXP... 
Via Benzinga
30 Stocks Moving In Tuesday's Mid-Day Session
Gainers ESS Tech Inc (NYSE: GWH) shares jumped 96.4% to $20.46. ESS Inc, the Bill Gates-backed battery maker went public on the New York Stock Exchange on Monday after... 
Via Benzinga
OCGN Stock: One Big Reason Ocugen Is Powering Higher Today
OCGN stock is making its investors quite happy this morning and prompting many more to pile in. The company is receiving crucial approval. 
Via InvestorPlace
Exposures COVID-19
Why Ocugen Stock Is on Fire Today
A positive regulatory development in India is sending the biotech's shares higher today. 
Via The Motley Fool
Exposures COVID-19
Why Ocugen's Stock Is Trading Higher Today
Ocugen Inc (NASDAQ: OCGN) is trading higher Tuesday after the Indian government approved Bharat Biotech's COVID-19 vaccine, Covaxin, for children between the age of... 
Via Benzinga
Exposures COVID-19
Ocugen Will Have Value If Its Covid Vaccine Can Get Approved
OCGN stock could be at a full value today given revenue prospects but could still rise if its Covaxin vaccine gains approval outside India. 
Via InvestorPlace
Exposures COVID-19 Product Safety
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Viridian Therapeutics (NASDAQ:VRDN) stock rose 22.49% to $19.17 during Tuesday's pre-market session. The company's market cap stands at $331.8 million. Inhibrx (... 
Via Benzinga
15 Stocks Moving in Tuesday's Pre-Market Session
Gainers Quanterix Corporation (NASDAQ: QTRX) shares rose 17.6% to $48.55 in pre-market trading after the company announced its Simoa phospho-Tau 181 blood test has been granted... 
Via Benzinga
Don’t Buy Too Much Into the WHO Hype Surrounding Ocugen Stock
The latest buzz around Covaxin does little to improve the prospects of OCGN stock, so buying it for this reason doesn't make much sense. 
Via InvestorPlace
Exposures COVID-19
Why Did Ocugen Stock Skyrocket On Monday?
Shares of biopharmaceutical company Ocugen Inc. (NASDAQ: OCGN) surged almost 8.8% in Monday’s regular trading session and also gained 11.4% in the after-hours session. What... 
Via Benzinga
OCUGEN INVESTIGATION CONTINUED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Ocugen, Inc. - OCGN
From Kahn Swick & Foti, LLC
Via Business Wire
WHO To Finalize Nod To Ocugen-Partnered Covaxin Next Week: Sources
The World Health Organization said a decision on the Emergency Use Listing (EUL) of India's COVID-19 vaccine, Covaxin, will be finalized next week. Ocugen Inc (... 
Via Benzinga
Exposures COVID-19
Ocugen Bulls Are Overlooking Its FDA Approval Hurdles
The FDA seems highly unlikely to approve the Covaxin vaccine, making OCGN stock an excellent name to short going forward. 
Via InvestorPlace
Exposures COVID-19 Product Safety
OCGN Stock: 2 Huge Reasons Ocugen Stock Is Shooting Higher Today
OCGN stock is surging on some big news. The World Health Organization could give the company the go-ahead on its Covid-19 vaccine very soon. 
Via InvestorPlace
Exposures COVID-19
Why Ocugen Shares Are Trading Higher Today
Ocugen Inc (NASDAQ: OCGN) is trading higher Tuesday after a company 8-K showed it entered into a Development and Commercial Supply Agreement with Bharat Biotech pursuant to... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Ocugen (NASDAQ:OCGN) shares moved upwards by 11.11% to $7.5 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.4... 
Via Benzinga
WHO Approval Won’t Move Ocugen Stock Very Much Over the Long Term
The WHO's nod of approval wont be fruitful to OCGN stock in blowing past the regulatory hurdles in the North American Covid 19 vaccine market. 
Via InvestorPlace
Exposures COVID-19
16 Stocks Moving in Tuesday's Pre-Market Session
Gainers Marine Petroleum Trust (NASDAQ: MARPS) rose 25.4% to $6.29 in pre-market trading after gaining 8% on Monday. Agrify Corporation. (NASDAQ: AGFY) rose 17.8% to $21.76 in... 
Via Benzinga
WHO To Decide On EUL Of Ocugen-Partnered COVID-19 Vaccine Today
An expert panel of the World Health Organization (WHO) will decide on the emergency use listing (EUL) authorization of Covaxin today. Covaxin is India's indigenously-... 
Via Benzinga
Exposures COVID-19
Ocugen Stock Just Needs a Catalyst to Break Free
OCGN stock holders should be patient as the World Health Organization's potential approval of an important vaccine could happen soon. 
Via InvestorPlace
Exposures COVID-19
It’s Time To Drop Ocugen Stock While You Still Can
Hope is one thing, but for OCGN stock investors expecting regulators or other bulls to come to the rescue, things are starting to look gloomy. 
Via InvestorPlace
Ocugen Still Lacks a Path to U.S. Profits
Ocugen still lacks a proper catalyst and nothing has changed for it. As a result, investors should avoid OCGN stock. 
Via InvestorPlace
Exposures COVID-19 Product Safety
Ocugen, Inc. (NASDAQ:OCGN) Long Term Investor Alert: Investigation of Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 09/28/2021 -- Certain directors of Ocugen, Inc are under investigation concerning potential breaches of fiduciary duties by certain directors of Ocugen, Inc. 
Via SBWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Ocugen-Partnered Covaxin's WHO Clearance Delayed Further Over Queries: Sources
The World Health Organization (WHO) has further delayed the emergency use authorization (EUA) for Covaxin, a COVID-19 vaccine developed in India. Ocugen Inc (NASDAQ:... 
Via Benzinga
Exposures COVID-19
Is Ocugen Worth Another Look After Good News for COVID Vaccine Covaxin?
An anticipated emergency use listing for the vaccine won't help Ocugen. 
Via The Motley Fool
Exposures COVID-19
Ocugen's India-Based Partner Concludes COVID-19 Vaccine Trials In Children: Report
India-based Bharat Biotech has completed the Phase 2 and 3 trials of COVID-19 vaccine, Covaxin, for use in 2 to 18 years. Ocugen Inc (NASDAQ: OCGN... 
Via Benzinga
Exposures COVID-19
It’s OK to Sell the News on Ocugen and Covaxin
OCGN stock jumped when Covaxin received WHO approval. But with two major obstacles in the way of U,S. approval, you should sell the news. 
Via InvestorPlace
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.